How the Pharmaceutical Industry is Tackling Scope 3 Emissions

January 4, 2022

The Energize supply chain decarbonization program brings together leading pharmaceutical companies to collaborate on reducing their Scope 3 emissions and mitigating the overall environmental impact of the pharmaceutical industry. By working with Schneider Electric and other leading pharmaceutical companies, Energize aims to assist pharmaceutical suppliers in adopting renewable energy by providing education and removing market barriers.

In this video, representatives from two pharmaceutical companies participating in this program, GSK and Novartis, talk about the goal of the program and the potential for this model to be scaled to other sectors.

Previous Article
2022 Sustainability Trends: Our Experts’ Top 10
2022 Sustainability Trends: Our Experts’ Top 10

Schneider Electric’s global energy and sustainability experts detail trends for 2022 for industry professio...

Next Video
2021 CDP Reporting Outcomes and Predictions for 2022
2021 CDP Reporting Outcomes and Predictions for 2022

Our sustainability experts share findings on the 2021 CDP scores, including insights from our clients and w...

NEW eGUIDE

A Practical Guide to Basic, Better, and Best Corporate ESG Reporting

DOWNLOAD